Effect of emicizumab on activated clotting time performed on i‐ STAT Alinity analyzer
International Journal of Laboratory Hematology · 2024-12 · 46 (6) · 1132-1135
DOI: 10.1111/ijlh.14343 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 18.07.2024. Verfasst von Landry Seyve und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Laboratory, Grenoble Alpes University Hospital, Grenoble, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hematology Laboratory, Grenoble Alpes University Hospital, Grenoble, France.
- Department of Anesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France.
- Unité Hémostase Clinique, Grenoble Alpes University Hospital, Grenoble, France.
- University Grenoble Alpes, TREE, CNRS UMR 5525, TIMC-IMAG, Grenoble, France.
ORCID-Profile: Caroline Lo Presti, Raphaël Marlu
Zitieren
APA
Seyve, L., Prigent, J. B., Lo Presti, C., Bédague, D., Szymanski, G., Bulabois, B., Barro, C., & Marlu, R. (2024). Effect of emicizumab on activated clotting time performed on i‐ STAT Alinity analyzer. International Journal of Laboratory Hematology, 46(6), 1132-1135. https://doi.org/10.1111/ijlh.14343
Vancouver
Seyve L, Prigent JB, Lo Presti C, Bédague D, Szymanski G, Bulabois B, et al. Effect of emicizumab on activated clotting time performed on i‐ STAT Alinity analyzer. International Journal of Laboratory Hematology. 2024;46(6):1132-1135. doi:10.1111/ijlh.14343
BibTeX
@article{Seyve2024,
author = {Seyve, Landry and Prigent, Jean Baptiste and Lo Presti, Caroline and Bédague, Damien and Szymanski, Gautier and Bulabois, Bénédicte and Barro, Claire and Marlu, Raphaël},
title = {Effect of emicizumab on activated clotting time performed on i‐ STAT Alinity analyzer},
journal = {International Journal of Laboratory Hematology},
year = {2024},
volume = {46},
number = {6},
pages = {1132--1135},
doi = {10.1111/ijlh.14343}
}
EUVIMED